Assure Holdings Sets Second Quarter 2023 Conference Call for Monday, August 14, 2023, at 5:30 p.m. ET
09 8월 2023 - 6:15AM
Assure Holdings Corp. (the “
Company” or
“
Assure”) (NASDAQ: IONM), a provider of
intraoperative neuromonitoring (“
IONM”) and remote
neurology services, will hold a conference call on Monday, August
14, 2023 at 5:30 p.m. Eastern Time to discuss its financial results
for the second quarter ended June 30, 2023.
The live webcast of the conference call and related
presentation slides can be accessed at
ir.assureneuromonitoring.com/news-events/ir-calendar. An audio-only
option is available by following the dial-in instructions below.
Investors who opt for audio-only will need to download the related
slides at
ir.assureneuromonitoring.com/company-information/presentations.
The Company will report its financial results in a press release
prior to the conference call.
Date: Monday, August 14, 2023 Time: 5:30 p.m. Eastern Time (3:30
p.m. Mountain Time) Toll-free dial-in number:
1-888-506-0062International dial-in number:
1-973-528-0011Conference ID: 211359
Please call the conference telephone number 5-10 minutes prior
to the start time. An operator will register your name and
organization.
The conference call will be broadcast live and available for
replay at: https://www.webcaster4.com/Webcast/Page/2566/48926.
A replay of the conference call will be available after 8:30
p.m. Eastern Time on the same day through Monday, August 28,
2023.
Toll-free replay number: 1-877-481-4010International replay
number: 1-919-882-2331Replay ID: 48926
About Assure Holdings
Assure Holdings Corp. is a best-in-class provider of outsourced
intraoperative neuromonitoring and remote neurology services. The
Company delivers a turnkey suite of clinical and operational
services to support surgeons and medical facilities during invasive
procedures that place the nervous system at risk including
neurosurgery, spine, cardiovascular, orthopedic and ear, nose and
throat surgeries. Assure employs highly trained technologists that
provide a direct point of contact in the operating room. Physicians
employed through Assure subsidiaries simultaneously monitor the
functional integrity of patients’ neural structures throughout the
procedure communicating in real-time with the surgeon and
technologist. Accredited by The Joint Commission, Assure’s mission
is to provide exceptional surgical care and a positive patient
experience. For more information, visit the company’s website at
www.assureneuromonitoring.com.
Forward-Looking Statements
This news release may contain “forward-looking statements”
within the meaning of applicable securities laws. Forward-looking
statements may generally be identified by the use of the words
"anticipates," "expects," "intends," "plans," "should," "could,"
"would," "may," "will," "believes," "estimates," "potential,"
"target," or "continue" and variations or similar expressions.
Forward-looking statements include, but are not limited to,
management’s expectations regarding the increase in procedures, and
other similar statements. These statements are based upon the
current expectations and beliefs of management and are subject to
certain risks and uncertainties that could cause actual results to
differ materially from those described in the forward-looking
statements. These risks include risks regarding our patient volume
or cases not growing as expected, or decreasing, which could impact
revenue and profitability; unfavorable economic conditions could
have an adverse effect on our business; risks related to increased
leverage resulting from incurring additional debt; the policies of
health insurance carriers may affect the amount of revenue we
receive; our ability to successfully market and sell our products
and services; we may be subject to competition and technological
risk which may impact the price and amount of services we can sell
and the nature of services we can provide; regulatory changes that
are unfavorable in the states where our operations are conducted or
concentrated; our ability to comply and the cost of compliance with
extensive existing regulation and any changes or amendments
thereto; changes within the medical industry and third-party
reimbursement policies and our estimates of associated timing and
costs with the same; our ability to adequately forecast expansion
and the Company’s management of anticipated growth; and risks and
uncertainties discussed in our most recent annual and quarterly
reports filed with the United States Securities and Exchange
Commission, including our annual report on Form 10-K filed on March
31, 2023, and with the Canadian securities regulators and available
on the Company’s profiles on EDGAR at www.sec.gov and SEDAR at
www.sedar.com, which risks and uncertainties are incorporated
herein by reference. Readers are cautioned not to place undue
reliance on forward-looking statements. Except as required by law,
Assure does not intend, and undertakes no obligation, to update any
forward-looking statements to reflect, in particular, new
information or future events.
Investor ContactBrett Maas, Managing Principal,
Hayden IR ionm@haydenir.com(646) 536-7331
Assure (NASDAQ:IONM)
과거 데이터 주식 차트
부터 4월(4) 2024 으로 5월(5) 2024
Assure (NASDAQ:IONM)
과거 데이터 주식 차트
부터 5월(5) 2023 으로 5월(5) 2024